SCHEMBL9734150

SCHEMBL9734150

O=C(O)CCC(=O)c1ccc(O)c(Cl)c1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ CYP1A2 P05177 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ NR4A2 P43354 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ HTT P42858 1/20 0.41
▸ USP5 P45974 1/20 0.40
▸ ADAM17 P78536 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ FFAR1 O14842 1/20 0.38
▸ LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11634523 0.84 NR4A2 (0.46) KMT2AALDH1A1CYP1A2KDM4EGLA
SCHEMBL9717586 0.83 MAPK1 (0.40) KMT2AALDH1A1HPGDHSD17B10MEN1
SCHEMBL7300776 0.81 TSHR (0.52) ALDH1A1HPGDHSD17B10HTTCYP3A4
SCHEMBL9717543 0.79 HTT (0.53) KMT2AALDH1A1MEN1HTT
SCHEMBL10846560 0.77 HSP90AB1 (0.53) KMT2AALDH1A1KDM4EPOLBHPGD
SCHEMBL11582407 0.76 CA1 (0.47) KMT2AALDH1A1CYP1A2KDM4EGLA
SCHEMBL2935246 0.76 CA1 (0.61) KMT2AALDH1A1KDM4EPOLBHPGD
SCHEMBL11710081 0.76 STING1 (0.52) KMT2AALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL11603708 0.76 HTT (0.58) KMT2AALDH1A1MEN1HTTFFAR1
SCHEMBL10356111 0.76 HTT (0.58) KMT2AALDH1A1MEN1HTTFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5135940-A Antiallegens, antiinflammatory agents MERCK FROSST CANADA, INC. (CA) 1992-08-04 — — US disclosed
EP-0252639-A1 Leukotriene antagonists MERCK FROSST CANADA INC. (CA) 1988-01-13 — — EP disclosed
EP-0104885-B1 LEUKOTRIENE ANTAGONISTS, THEIR PRODUCTION, AND COMPOSITIONS CONTAINING THEM MERCK FROSST CANADA INC. (CA) 1986-06-04 — — EP disclosed
EP-0156233-A2 Use of leukotriene antagonists for producing cytoprotective pharmaceutical compositions and process for producing cytoprotective pharmaceutical compositions MERCK & CO. INC. (US) 1985-10-02 — — EP disclosed
EP-0104885-A1 Leukotriene antagonists, their production, and compositions containing them MERCK FROSST CANADA INC. (CA) 1984-04-04 — — EP disclosed
Send feedback